Insider Trading - Edgewise Therapeutics Inc. (EWTX)
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-30 Purchase | 2021-03-30 3:42 pm | Edgewise Therapeutics Inc. | EWTX | Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. 10% Owner | 625,000 | $16 | $10,000,000 | 3,933,137 (Indirect) | View |
| 2021-03-30 Purchase | 2021-03-31 4:36 pm | Edgewise Therapeutics Inc. | EWTX | Novo Holdings A/S 10% Owner | 625,000 | $16 | $10,000,000 | 5,587,207 (Direct) | View |
| 2021-03-30 Purchase | 2021-03-31 7:10 pm | Edgewise Therapeutics Inc. | EWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner | 359,375 | $16 | $5,750,000 | 13,359,456 (Indirect) | View |
| 2021-03-30 Purchase | 2021-03-31 7:11 pm | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 359,375 | $16 | $5,750,000 | 13,359,456 (Indirect) | View |
| 2021-03-30 Purchase | 2021-03-31 7:12 pm | Edgewise Therapeutics Inc. | EWTX | ROOT JONATHAN D Director | 15,625 | $16 | $250,000 | 3,489,168 (Indirect Direct) | View |
| 2021-09-23 Sale | 2021-09-27 7:32 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 58,546 | $18.3 | $1,071,422 | 205,554 (Direct) | View |
| 2021-09-28 Sale | 2021-09-30 7:16 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 26,454 | $17.1 | $452,483 | 179,100 (Direct) | View |
| 2021-10-01 Sale | 2021-10-05 6:33 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 5,778 | $18.24 | $105,409 | 173,322 (Direct) | View |
| 2021-10-06 Sale | 2021-10-08 6:00 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 21,028 | $18.39 | $386,743 | 152,294 (Direct) | View |
| 2021-10-11 Sale | 2021-10-13 6:51 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 1,270 | $18.02 | $22,885 | 151,024 (Direct) | View |
| 2021-10-14 Sale | 2021-10-18 7:48 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 7,182 | $18.17 | $130,483 | 143,842 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 7:00 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 44,172 | $17.88 | $789,909 | 99,670 (Direct) | View |
| 2021-11-04 Sale | 2021-11-08 7:11 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 29,451 | $19.82 | $583,823 | 70,219 (Direct) | View |
| 2021-11-09 Sale | 2021-11-12 5:24 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 69,740 | $19.91 | $1,388,788 | 479 (Direct) | View |
| 2021-11-15 Sale | 2021-11-17 6:05 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 479 | $19.11 | $9,155 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-30 Conversion | 2021-03-30 3:42 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. 10% Owner | 3,308,137 | $0 | 3,933,137 (Indirect) | View |
| 2021-03-30 Conversion | 2021-03-30 5:12 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 681,812 | $0 | 681,812 (Direct) | View |
| 2021-03-30 Conversion | 2021-03-31 4:36 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Novo Holdings A/S 10% Owner | 9,924,414 | $0 | 5,587,207 (Direct) | View |
| 2021-03-30 Conversion | 2021-03-31 7:10 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner | 25,732,796 | $0 | 13,359,456 (Indirect) | View |
| 2021-03-30 Conversion | 2021-03-31 7:11 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 25,732,796 | $0 | 13,359,456 (Indirect) | View |
| 2021-03-30 Conversion | 2021-03-31 7:12 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | ROOT JONATHAN D Director | 6,947,086 | $0 | 3,489,168 (Indirect) | View |
| 2021-04-30 Option Award | 2021-05-04 4:34 pm | N/A 2031-04-30 | Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO | 160,000 | $0 | 160,000 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-19 5:09 pm | N/A 2031-08-17 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN CEO | 400,000 | $0 | 400,000 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-19 5:09 pm | N/A 2031-08-17 | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael CFO | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-19 5:09 pm | N/A 2031-08-17 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-19 5:09 pm | N/A 2031-08-17 | Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO | 160,000 | $0 | 160,000 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-19 5:09 pm | N/A 2031-08-17 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-19 5:10 pm | N/A 2031-08-17 | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-11-30 Exercise | 2021-12-01 6:20 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 147,585 | $0.18 | 302,937 (Direct) | View |
| 2021-11-30 Exercise | 2021-12-01 6:20 pm | N/A 2027-08-08 | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 172,585 | $0 | 302,937 (Direct) | View |
| 2021-11-30 Exercise | 2021-12-01 6:20 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 25,000 | $0.45 | 302,937 (Direct) | View |